Automated Molecular Diagnostic System Transforms Lab Experience

The BioCode MDx-3000 molecular diagnostic system from Applied BioCode, Inc. (Santa Fe Springs, CA, USA) is a user-friendly instrument based on a 96-well microplate format. It automates detection steps, PCR amplification, and hybridization and target capture. The cost-effective, high-throughput multiplex system features a simple design with a touch screen, handheld scanner, and LIS connectivity. It allows for simultaneous testing of up to three different panels in a single run and minimizes the risk of contamination.

The BioCode MDx-3000 system supports efficient and accurate testing for infectious diseases by utilizing BioCode assays, such as the Gastrointestinal Pathogen Panel, Respiratory Pathogen Panel, CoV-2 Flu Plus Assay, and SARS-CoV-2 Assay. The BioCode Gastrointestinal Pathogen Panel employs reliable Barcoded Magnetic Beads technology to detect specific gastrointestinal microbial nucleic acid from individuals exhibiting infection signs and symptoms. The flexible, cost-effective, comprehensive molecular test identifies the 17 most common causative pathogens in raw stool specimens or stool in Cary-Blair medium from symptomatic patients.

The BioCode Respiratory Pathogen Panel is a qualitative multiplexed nucleic acid-based in vitro diagnostic test that can simultaneously detect and identify nucleic acids from multiple viruses and bacteria extracted from nasopharyngeal swab (NPS) samples obtained from individuals with signs and/or symptoms of respiratory tract infection. The BioCode CoV-2 Flu Plus Assay is a multiplexed nucleic acid test designed for the qualitative detection and differentiation of RNA from SARS-CoV-2, Influenza A, Influenza B, and/or Respiratory Syncytial Virus (RSV) in nasopharyngeal swabs. It can be run as an independent assay or concurrently with the FDA-cleared BioCode Respiratory Pathogen Panel to provide a more comprehensive respiratory infection profile for patients. The BioCode SARS-CoV-2 Assay is designed to detect two different conserved regions of the SARS-CoV-2 N gene.

Related Links:
Applied BioCode, Inc.